Fig. 6: Proposed model of JQ1 and palbociclib activity in cisplatin-sensitive and resistant cell lines.

a HNSCC cell at baseline. b HNSCC cell sensitive to cisplatin. c Cisplatin resistance confers palbociclib resistance. d JQ1 combined with palbociclib overcomes cisplatin resistance